Abstract
Background
Although the majority of cases of acute central serous chorioretinopathy are self-limited, resolving spontaneously after a number of weeks, the recurrence rate is estimated to be 20–50 %, and some cases will be chronic, lasting 6 months or longer. The evidence of Helicobacter pylori infection appears more often in patients with central serous chorioretinopathy. The purpose of this work was to estimate the efficiency of H. pylori infection eradication in treatment of patients with acute central serous chorioretinopathy.
Methods
Ninety-three patients with acute central serous chorioretinopathy participated in this study. Patients were divided into an experimental group (33 Helicobacter pylori-positive patients who received eradication treatment) and two control groups who did not receive eradication treatment: 29 H. pylori-positive patients and 31 H. pylori-negative patients. Research methods were best-corrected Snellen visual acuity, optical coherence tomography, fluorescein angiography. Research methods were best-corrected Snellen visual acuity, optical coherence tomography, static perimetry, and Amsler grid. The follow-up period was 2 years.
Results
Helicobacter pylori eradication caused a decrease of disease duration at 3 months (p = 0.04) and recurrence frequency of 45.6 % (p = 0.03) as well as improvement of distant prognosis. After 2 years, visual acuity increased from 0.91 ± 0.07 to 0.99 ± 0.02 (p = 0.01), scotoma frequency decreased from 100 % eyes to 27.2 % (p = 0.001), and metamorphopsia frequency decreased from 57.6 % eyes to 39.4 % (p = 0.04).
Conclusions
Helicobacter pylori eradication is effective in the treatment of H. pylori-positive patients with acute central serous chorioretinopathy.
Similar content being viewed by others
References
Spaide RF, Campeas L, Haas A, Yannuzzi LA, Fisher YL, Guyer DR, Slakter JS, Sorenson JA, Orlock DA (1996) Central serous chorioretinopathy in younger and older adults. Ophthalmology 103:2070–2079, discussion 2079–2080
Otsuka S, Ohba N, Nakao K (2002) A long-term follow-up study of severe variant of central serous chorioretinopathy. Retina 22:25–32
Kitzmann AS, Pulido JS, Diehl NN, Hodge DO, Burke JP (2008) The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980–2002. Ophthalmology 115(1):169–73. doi:10.1016/j.ophtha.2007.02.032
Fok AC, Chan PP, Lam DS, Lai TY (2011) Risk factors for recurrence of serous macular detachment in untreated patients with central serous chorioretinopathy. Ophthalmic Res 46(3):160–3. doi:10.1159/000324599
Piccolino FC, de la Longrais RR, Ravera G, Eandi CM, Ventre L, Abdollahi A, Manea M (2005) The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy. Am J Ophthalmol 139(1):87–99
Wang M, Munch IM, Hasler PW, Prünte C, Larsen M (2008) Central serous chorioretinopathy. Acta Ophthalmol 86:126–145. doi:10.1111/j.1600-0420.2007.00889.x
Kim SW, Oh J, Huh K (2012) Correlations among various functional and morphological tests in resolved central serous chorioretinopathy. Br J Ophthalmol 96(3):350–5. doi:10.1136/bjo.2011.204503
Kitaya N, Nagaoka T, Hikichi T, Sugawara R, Fukui K, Ishiko S, Yoshida A (2003) Features of abnormal choroidal circulation in central serous chorioretinopathy. Br J Ophthalmol 87(6):709–12
Manolakis A, Kapsoritakis AN, Potamianos SP (2007) A review of the postulated mechanisms concerning the association of Helicobacter pylori with ischemic heart. Helicobacter 12(4):287–97
Franceschi F, Roccarina D, Gasbarrini A (2006) Extragastric manifestations of Helicobacter pylori infection. Minerva Med 97(1):39–45
Franceschi F, Navarese EP, Mollo R, Giupponi B, De Marco G, Merra G, Gasbarrini G, Silveri NG (2009) Helicobacter pylori and atherosclerosis. A review of the literature. Article in Italian. Recenti Prog Med 100(2):91–6
Franceschi F, Niccoli G, Ferrante G, Gasbarrini A, Baldi A, Candelli M, Feroce F, Saulnier N, Conte M, Roccarina D, Lanza GA, Gasbarrini G, Gentiloni SN, Crea F (2009) CagA antigen of Helicobacter pylori and coronary instability: insight from a clinico-pathological study and a meta-analysis of 4241 cases. Atherosclerosis 202(2):535–42. doi:10.1016/j.atherosclerosis.2008.04.051
De Bastiani R, Gabrielli M, Ubaldi E, Benedetto E, Sanna G, Cottone C, Candelli M, Zocco MA, Saulnier N, Santoliquido A, Papaleo P, Gasbarrini G, Gasbarrini A (2008) High prevalence of Cag-A-positive H. pylori strains in ischemic stroke: a primary care multicenter study. Helicobacter 13(4):274–7. doi:10.1111/j.1523-5378.2008.00610.x
Georges JL, Rupprecht HJ, Blankenberg S, Poirier O, Bickel C, Hafner G, Nicaud V, Meyer J, Cambien F, Tiret L, AtheroGene Group (2003) Impact of pathogen burden in patients with coronary artery disease in relation to systemic inflammation and variation in genes encoding cytokines. Am J Cardiol 92(5):515–21
Giusti C, Mauget-Faÿsse M (2004) Helicobacter pylori and idiopathic central serous chorioretinopathy. Swiss Med Wkly 134(27–28):395–8
Whittle BJ, Morschl E, Pozsár J, Moran AP, László F (2001) Helicobacter pylori lipopolysaccharide provokes iNOS-mediated acute systemic microvascular inflammatory responses in rat cardiac, hepatic, renal and pulmonary tissues. J Physiol Paris 95(1–6):257–9
Giusti C (2004) Association of Helicobacter pylori with central serous chorioretinopathy: hypotheses regarding pathogenesis. Med Hypotheses 63(3):524–7
Giusti C (2001) Central serous chorioretinopathy: a new extragastric manifestation of Helicobacter pylori?: Analysis of a clinical case. Article in Italian. Clin Ter 152(6):393–7
Mauget-Faÿsse M, Kodjikian L, Quaranta M, Ben Ezra D, Trepsat C, Mion F, Mégraud F (2002) Helicobacter pylori in central serous chorioretinopathy and diffuse retinal epitheliopathy. Results of the first prospective pilot study. Article in French. J Fr 25(10):1021–1025
Ahnoux-Zabsonre A, Quaranta M, Mauget-Faysse M (2004) Pre’valence de l’Helicobacter pylori dans la choriore’tinopathie se’reuse centrale et l’e’pithe’liopathie re’tinienne diffuse. J Fr Ophtalmol 27:1129–1133
Asensio-Sánchez VM, Rodríguez-Delgado B, García-Herrero E, Cabo-Vaquera V, García-Loygorri C (2008) Central serous chorioretinopathy as an extradigestive manifestation of Helicobacter pylori gastric infection. Article in Spanish. Arch Soc Esp Oftalmol 83:177–182
Cotticelli L, Borrelli M, D'Alessio AC, Menzione M, Villani A, Piccolo G, Montella F, Iovene MR, Romano M (2006) Central serous chorioretinopathy and Helicobacter pylori. Eur J Ophthalmol 16(2):274–8
Misiuk-Hojło M, Michałowska M, Zołyńska M (2007) Helicobacter pylori-a risk factor for the development of the central serous chorioretinopathy. Klin Oczna 109(10–12):479–481
Abreu R, Nadal J, Abreu P (2008) Helicobacter pylori and central serous chorioretinopathy. Arch Soc Esp Oftalmol 83(11):637–8
Rahbani-Nobar MB, Javadzadeh A, Ghojazadeh L, Rafeey M, Ghorbanihaghjo A (2011) The effect of Helicobacter pylori treatment on remission of idiopathic central serous chorioretinopathy. Mol Vis 17:99–103
Casella AMB, Berbel RF, Bressanim GL, Malaguido MR, Cardillo JA (2012) Helicobacter pylori as a potential target for the treatment of central serous chorioretinopathy. Clinics (Sao Paulo) 67(9):1047–1052. doi:10.6061/clinics/2012(09)11
Dang Y, Mu Y, Zhao M, Li L, Guo Y, Zhu Y (2013) The effect of eradicating Helicobacter pylori on idiopathic central serous chorioretinopathy patients. Ther Clin Risk Manag 9:355–60
Gatta L, Ricci C, Tampieri A, Osborn J, Perna F, Bernabucci V, Vaira D (2005) Accuracy of breath tests using low doses of 13C-urea to diagnose Helicobacter pylori infection: a randomised controlled trial. Gut 55:457–462. doi:10.1136/gut.2005.078626
Calvet X, Sánchez-Delgado J, Montserrat A, Lario S, Ramírez-Lázaro MJ, Quesada M, Casalots A, Suárez D, Campo R, Brullet E, Junquera F, Sanfeliu I, Segura F (2009) Accuracy of diagnostic tests for Helicobacter pylori: a reappraisal. Clin Infect Dis 48:1385–91. doi:10.1086/598198
Al-Humayed SM, Ahmed ME, Bello CS, Tayyar MA (2008) Comparison of 4 laboratory methods for detection of Helicobacter pylori. Saudi Med J 29:530–2
Redéen S, Petersson F, Törnkrantz E, Levander H, Mårdh E, Borch K (2011) Reliability of diagnostic tests for Helicobacter pylori infection. Gastroenterol Res Pract 2011:940650. doi:10.1155/2011/940650
Mégraud F, Bessède E, Lehours P (2014) Current methods used for the diagnosis of Helicobacter pylori infection. In: Buzás GM (ed) Helicobacter pylori - A Worldwide Perspective 2014. Bentham Science, Oak Park, pp 234–58
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Conflict of interest
The author(s) declare that they have no competing interests.
Financial disclosures
The authors have no financial interest in any of the materials used in this study.
Rights and permissions
About this article
Cite this article
Zavoloka, O., Bezditko, P., Lahorzhevska, I. et al. Clinical efficiency of Helicobacter pylori eradication in the treatment of patients with acute central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol 254, 1737–1742 (2016). https://doi.org/10.1007/s00417-016-3315-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-016-3315-0